ArticleBioresources and bioprocessing2025
Analysis of cultivation conditions and enzymatic efficiency enables high-yield levan production from Bacillus velezensis KKSB6.
Article in Bioresources and bioprocessing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent Advances in Microbial Levan Production: Strategies for Yield Enhancement and Sustainability.International journal of food science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Levan, a fructose-based biopolymer with significant industrial potential, was produced using the native strain Bacillus velezensis KKSB6. This study aimed to optimize levan production through different cultivation strategies and to characterize the enzyme responsible, levansucrase. Production was compared in batch, fed-batch and continuous systems, revealing a critical point between final yield and productivity. Batch cultivation achieved a high levan yield of 187 g/L (93.50% yield), while a fed-batch cultivation delivered high productivity at 3.46 g/L/h but a low levan yield (55.33%). Continuous cultivation demonstrated the highest levan production of 746 g/L (93.25% yield) and high productivity (7.77 g/L/h). In those systems, production was limited by the inhibitory effect of glucose accumulation. The purified levansucrase, a 42 kDa protein, exhibited optimal activity at 35 °C and pH 7.0. Significantly, in vitro synthesis using the purified enzyme produced primarily high-molecular-weight (HMW) levan, in contrast to the lower-molecular-weight product obtained from whole-cell fermentation. In conclusion, B. velezensis KKSB6 is an exceptionally potent strain, with batch cultivation or continuous cultivation producing levan yield and with continuous cultivation favoring productivity. The purified enzyme represents a promising biocatalyst for the targeted synthesis of HMW levan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.